Screening
MicroPhage's MRSA/MSSA screening test will identify methicillin-resistant S. aureus (MRSA) and methicillin-sensitive S. aureus (MSSA) only 12 hours through a simple lateral flow test design.
A powerful tool
Active surveillance can help hospitals reduce these infections. MicroPhage's bacteriophage amplification test will have the performance of PCR at an affordable price. MicroPhage's MRSA/MSSA screening test design is ideal for any institution concerned with testing for MRSA/MSSA in their patients. Built on our easy-to-use platform, MRSA screening test allows for simple, unbatched test starts and batched or unbatched results.
